Fermenta Biotech Ltd.
FERMENTA
Rank in Stocks
#18241
Fermenta Biotech Ltd. primarily focuses on the creation and provision of... Fermenta Biotech Ltd. primarily focuses on the creation and provision of Vitamin D3. Their extensive range of offerings includes various forms like crystalline, oil, resin in oil, cold water dispersible (CWD) preparations, and feed-grade powder. These adaptable products are utilized across multiple sectors, such as in pharmaceutical injectables, soft gel capsules, premixes, and for enhancing the nutritional value of food and beverages. The company's business activities are structured into two main divisions: the Chemicals/Bulk Drug segment, which involves the production and sale of chemicals, pharmaceutical ingredients, and enzymes; and the Property segment, dedicated to leasing out real estate. Established on May 1, 1951, by Vijay Kumar Raju Datla, the firm maintains its headquarters in Mumbai, India.
Share Price
$4.87
Last synced: 2026-11-18
Market Cap
$136.31M
Change (1 day)
-1.52%
Change (1 year)
54.90%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fermenta Biotech Ltd. (FERMENTA)
Category
Healthcare
EPS for Fermenta Biotech Ltd. (FERMENTA)
EPS as of September 2026 TTM: $0.19
According to Fermenta Biotech Ltd.'s latest financial reports, its current EPS (TTM) is $0.19. At the end of 2025 the company had an EPS of $0.31, an increase over its 2024 EPS of $-0.10.
EPS history for Fermenta Biotech Ltd. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.19 | -39.71% |
| 2025 | $0.31 | -423.07% |
| 2024 | $-0.10 | -55.52% |
| 2023 | $-0.22 | -405.53% |
| 2022 | $0.07 | -67.27% |
| 2021 | $0.22 | -21.33% |
| 2020 | $0.27 | -55.45% |
| 2019 | $0.61 | 226.74% |
| 2018 | $0.19 | -393.91% |
| 2017 | $-0.06 | 932.26% |
| 2016 | $-0.01 | -329.63% |
| 2015 | 0.00 | -94.34% |
| 2014 | $0.05 | 71.58% |
| 2013 | $0.03 | -82.57% |
| 2012 | $0.16 | -22.72% |
| 2011 | $0.21 | 121.22% |
| 2010 | $0.09 | 123.21% |
| 2009 | $0.04 | -34.38% |
| 2008 | $0.06 | -13.69% |
| 2007 | $0.07 | 326.59% |
| 2006 | $0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -576.19% |
US
|
|
| $15.66 | 8,278.81% |
US
|
|
| $-7.07 | -3,882.77% |
US
|
|
| $-5.29 | -2,930.39% |
AU
|
|
| $12.73 | 6,712.31% |
BE
|
Questions about Fermenta Biotech Ltd.'s earnings per share (EPS)
What is Fermenta Biotech Ltd.'s earnings per share (EPS)?
Fermenta Biotech Ltd.'s earnings per share (EPS) over the last twelve months is $0.19, as of Sep 2026.
What was Fermenta Biotech Ltd.'s earnings per share (EPS) in 2025?
In 2025, Fermenta Biotech Ltd.'s earnings per share (EPS) was $0.31, compared with $-0.10 in 2024.
How has Fermenta Biotech Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fermenta Biotech Ltd.'s earnings per share (EPS) went from $0.27 to $0.31, an average growth of 2.80% a year.
How does Fermenta Biotech Ltd.'s earnings per share (EPS) compare with similar companies?
Fermenta Biotech Ltd.'s earnings per share (EPS) ($0.19) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.